{"id":481498,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2023-12-22] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:50:20.518000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2023-12-22.html?wbdisable=true","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2023-12-22] December 22, 2023 Our file number: 23-111963-914 The purpose of this Notice of Amendment is to notify about the addition of avatrombopag, calaspargase pegol, efgartigimod alfa, evinacumab, odevixibat,…","rawSnapshotUrl":"/api/snapshots/raw/481498","browseUrl":"https://replay.healtharchive.ca/job-6/20260106165020/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2023-12-22.html?wbdisable=true#ha_snapshot=481498","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}